Kelly Langert

Kelly Langert, PhD is an Assistant Professor in the Department of Molecular Pharmacology & Neuroscience at Loyola University Chicago’s Stritch School of Medicine. Her research focuses on advancing targeted drug delivery systems for inflammatory neuropathies using biodegradable nanoparticles and investigating GTPase signaling pathways in endothelial cells. Her work bridges pharmacology, neuroscience, and bioengineering to develop therapies addressing conditions like autoimmune neuritis and peripheral neuropathies.

Her research interests include:

• Targeted drug delivery via nanoparticle engineering
• Monomeric GTPase signaling in blood-nerve barrier dynamics
• Novel therapeutic targets at leukocyte-endothelial interfaces

Recent publications highlight advancements in chitosan-PLGA nanoparticle formulations, statin pleiotropy, and blood-nerve barrier permeability studies. Her work emphasizes translational applications of nanoparticle-based drug delivery systems in peripheral nerve disorders.

Dr. Langert’s lab operates within the Stritch School of Medicine, focusing on interdisciplinary approaches to neurovascular inflammation and therapeutic development. No awards or grants are explicitly listed in the provided materials.